Green Eric Mark 4

What Happened
Eric Mark Green, President, CEO and Board Chair of West Pharmaceutical Services, received two derivative awards on March 1, 2026: 6,986 restricted stock units (RSUs) and 16,630 stock options. Both grants show $0 cash paid at grant (typical for compensation awards) and together represent a potential 23,616 shares subject to future vesting and any option terms.

Key Details

• Transaction date: 2026-03-01; Form 4 filed: 2026-03-03 (filed within the normal two-business-day window).
• Award amounts: 6,986 RSUs and 16,630 stock options; reported acquisition price: $0.00 (no cash paid at grant).
• Vesting: Both awards vest in four equal annual installments beginning March 1, 2027 (per footnotes).
• Footnotes: F1 — each RSU converts to one share upon vesting; F2 — RSU vesting schedule; F3 — option vesting schedule.
• Shares owned after the transaction: not specified in the provided filing excerpt.

Context
RSUs and stock-option grants are standard long-term incentive compensation for executives; they do not represent open-market purchases or sales and do not indicate immediate buying or selling of shares. Options must vest before they can be exercised, and RSUs convert to shares only upon vesting and any required settlement. This filing documents the grant date and vesting schedule rather than any cash transaction or share disposition.